Transposagen Biopharmaceuticals
UEI: C2NNG8Q4C2J5
Overview
Awardee Type
Parent
(1 child)
Name
Transposagen Biopharmaceuticals
Headquarters
Lexington, KY
United States
United States
Most Recent Award
Sept. 18, 2014
Calculating
Federal contract and grant recipient
TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
(UEI C2NNG8Q4C2J5)
is headquartered in Lexington KY.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in October 2003 and
federally registered in
January 2006.
Federal Award Analysis
Transposagen Biopharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI J6ZQV1E66G99 CAGE 499Y3 instead.
Legal Name
TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
UEI
J6ZQV1E66G99
CAGE Code
499Y3
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Oct. 31, 2003
Initial Registration
Jan. 9, 2006
Last Registration
Aug. 13, 2019
Registration Activation
Aug. 13, 2018
Registration Expiration
Aug. 13, 2019
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No